Van beleggers
voor beleggers
desktop iconMarkt Monitor

Ontvang nu dagelijks onze kooptips!

word abonnee

Aandeel OpGen OTC:OPGN.Q, US68373L3078

  • 0,120 9 dec 2022 21:59
  • 0,000 (0,00%) Dagrange 0,116 - 0,137
  • 1.241.821 Gem. (3M) 402,3K

Curetis-OpGen - 2020: wordt het nog wat..?

2.575 Posts
Pagina: «« 1 ... 120 121 122 123 124 ... 129 »» | Laatste | Omlaag ↓
  1. forum rang 5 N13k 20 augustus 2020 14:17
    quote:

    Bones schreef op 20 augustus 2020 13:43:

    Wel ingestapt toch?

    Voorbeurs 3,12 +1,07 (52,20%)
    Als gevolg van:

    www.globenewswire.com/news-release/20...

    OpGen Announces CE-IVD Marking and Commercial Launch in Europe of its Own Developed Molecular Diagnostic SARS-CoV-2 Kit with PULB for Detection of the Virus Causing COVID-19

    - Own developed SARS-CoV-2 Kit with PULB for COVID-19 uses real-time PCR (RT-PCR) technology on open PCR platforms, designed to provide results in approximately one hour

    - 100% Sensitivity and 97.3% Specificity demonstrated in isolated RNA

    - Inclusion of PCR-Compatible Universal Lysis Buffer (PULB) in the kit as a workflow option allows labs to circumvent the need for extraction equipment and reagents

    GAITHERSBURG, Md., and HOLZGERLINGEN, Germany, Aug. 20, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, announced today that its subsidiary Curetis GmbH has obtained the CE mark certification in the European Union for its own SARS-CoV-2 Kit with PULB for the detection of SARS-CoV-2, the virus that causes COVID-19.

    Developed and manufactured by Curetis’ team in Germany, the SARS-CoV-2 Kit with PULB uses real-time reverse transcription polymerase chain reaction (RT-PCR) technology for qualitative detection of the SARS-CoV-2 virus isolated from oropharyngeal and nasopharyngeal swab specimens from individuals suspected of COVID-19 by their healthcare provider or for screening of asymptomatic individuals. This kit can be used with RNA isolated by performing standard RNA isolation processes, as well as with oropharyngeal or nasopharyngeal swabs collected in PCR compatible viral transport medium treated with PCR-Compatible Universal Lysis Buffer (PULB) provided in the kit. Including PULB in the kit as a workflow option allows labs to circumvent the need for extraction equipment and extraction kits/reagents, thereby providing operational and workflow efficiencies, time and cost savings. The kit is designed to provide time to results in approximately one hour, and it runs on open real-time PCR instruments such as the QuantStudio™ 5 Real-Time PCR System and the Bio-Rad CFX96™ Real-Time PCR Detection System.

    “The CE-IVD Marking is an important step in advancing our efforts to support critical COVID-19 testing; the Curetis SARS-CoV-2 Kit with PULB provides additional testing capacity in countries that recognize the CE Mark to test patients,” said Johannes Bacher, COO of OpGen.

    “By launching this new product in Europe, we are committed to helping our distributors and customers to expand the availability of SARS-CoV-2 diagnostic testing, and our own-developed CE-IVD marked SARS-CoV-2 Kit with PULB is expected to help increase availability of these much-needed tests," said Oliver Schacht, PhD, CEO of OpGen. “Our customers will benefit from an optimized workflow and a test that delivers great performance and significantly shorter time-to-result at favorable economics compared to many of the commercially available open PCR platform COVID-19 tests including the BGI SARS-CoV-2 kit. Having access to our own SARS-CoV-2 kit allows us to have that product distributed rather than the BGI test kit which we will cease distributing effective immediately.”
  2. forum rang 10 DeZwarteRidder 25 augustus 2020 09:03
    quote:

    Pitmans schreef op 25 augustus 2020 08:01:

    Grappig, een 'persbureau' waar je ongecheckt je PB's kunt publiceren. En dan zorgen zij dat het er betrouwbaar uitziet.
    Ze zijn in ieder geval goedkoper dan Harry Mens, dat pleit voor ze.
    Ik denk dat ze een deel van de winst willen hebben.
2.575 Posts
Pagina: «« 1 ... 120 121 122 123 124 ... 129 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord

Direct naar Forum

OpGen Meer »

Koers 0,120   Verschil 0,00 (0,00%)
Laag 0,116   Volume 1.241.821
Hoog 0,137   Gem. Volume 402.251
9 dec 2022 21:59
Premium drie voorbeelden van IEX Premium: de exclusieve content op de site, de app op een smartphone en IEX Magazine.

KOPEN OF VERKOPEN?

Het laatste advies leest u als IEX Premium-lid

Ontdek Premium

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links